Dawn C. Bir
2020
In 2020, Dawn C. Bir earned a total compensation of $3.9M as Chief Commercial Officer and Executive Vice President at REATA PHARMACEUTICALS, a 96% increase compared to previous year.
Compensation breakdown
| Bonus | $239,900 |
|---|---|
| Option Awards | $3,204,642 |
| Salary | $422,000 |
| Other | $5,000 |
| Total | $3,871,542 |
Bir received $3.2M in option awards, accounting for 83% of the total pay in 2020.
Bir also received $239.9K in bonus, $422K in salary and $5K in other compensation.
Rankings
In 2020, Dawn C. Bir's compensation ranked 2,958th out of 13,090 executives tracked by ExecPay. In other words, Bir earned more than 77.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,958 out of 13,090 | 77th |
Division Manufacturing | 1,150 out of 5,620 | 80th |
Major group Chemicals And Allied Products | 429 out of 2,253 | 81st |
Industry group Drugs | 372 out of 1,953 | 81st |
Industry Pharmaceutical Preparations | 275 out of 1,458 | 81st |
Pay ratio
| Dawn C. Bir's Pay | $3,871,542 |
|---|---|
| Median Employee's Pay | $568,580 |
| Pay Ratio | 7to 1 |
In 2020, the annual total compensation of Dawn C. Bir was $3,871,542.
The annual total compensation of the median employee at REATA PHARMACEUTICALS was $568,580.
The ratio of Dawn C. Bir's pay to the pay of median employee was therefore 7 to one.
Source: SEC filing on April 30, 2021.
Bir's colleagues
We found four more compensation records of executives who worked with Dawn C. Bir at REATA PHARMACEUTICALS in 2020.